JAKAVI
NOVARTIS PHARMACEUTICALS CANADA INC
Quick answers
Is there a shortage of JAKAVI in Canada?
No. There is no current shortage of JAKAVI 20MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
JAKAVI
NOVARTIS PHARMACEUTICALS CANADA INC
OPZELURA
INCYTE CORPORATION
DIN
02388022
Strength
20MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
RUXOLITINIB (RUXOLITINIB PHOSPHATE)
See all RUXOLITINIB (RUXOLITINIB PHOSPHATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NOVARTIS PHARMACEUTICALS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2.5MG · DIN 02369257
10MG · DIN 02339528
5MG · DIN 02339501
7.5MG · DIN 02450267
2MG · DIN 02425645
5MG · DIN 02425661
3MG · DIN 02425653
140MG · DIN 02487306
70MG · DIN 02479613
0.1% · DIN 00893560
100MG · DIN 02381559
1000MG · DIN 02381567